Physiological insights and clinical evidence of high flow nasal cannula as first-line therapy for acute hypercapnic exacerbation of COPD: a narrative review.
INTRODUCTION Chronic obstructive pulmonary disease is a common lung disease. Acute exacerbations (AECOPD) are associated with increased hospitalisations and mortality. Current guidelines provide only conditional recommendation for the use of High Flow Nasal Cannula (HFNC) supported by low-certainty evidence in hypercap...